(KNSA) |
| 0 (0%) 02-28 06:26 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 49.12 |
| Resistance 1: | 46.21 |
| Pivot price: | 44.95 |
| Support 1: | 41.50 |
| Support 2: | 34.53 |
| 52w High: | |
| 52w Low: |
| EPS | 0.450 |
| Book Value | 7.100 |
| PEG Ratio | 0.00 |
| Gross Profit | 6.989 |
| Profit Margin (%) | 6.01 |
| Operating Margin (%) | 13.28 |
| Return on Assets (ttm) | 3.8 |
| Return on Equity (ttm) | 7.4 |
Fri, 27 Feb 2026
KNSA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Fri, 27 Feb 2026
Kiniksa Pharmaceuticals (NASDAQ:KNSA): A Prime Example of Affordable Growth (GARP) Investing - ChartMill
Fri, 27 Feb 2026
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Upgraded at Zacks Research - MarketBeat
Fri, 27 Feb 2026
Is Kiniksa Pharmaceuticals (KNSA) Still Attractive After A 114% One-Year Share Price Surge? - simplywall.st
Thu, 26 Feb 2026
Kiniksa Pharmaceuticals International (KNSA) Profitability Shift Tests Bullish High Growth Narratives - simplywall.st
Wed, 25 Feb 2026
(KNSA) Volatility Zones as Tactical Triggers - Stock Traders Daily
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |